Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal

OBJECTIVES: The objectives of this study were to explore the mechanisms of metformin sensitization to hypoxia-induced gefitinib treatment in resistant head and neck squamous cell carcinoma (HNSCC) and evaluate the effects of this combined treatment strategy. METHODS: The effects of gefitinib treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xiteng, Wei, Zheng, Song, Chuanhui, Tang, Chuanchao, Xu, Wenguang, Wang, Yufeng, Xie, Junqi, Lin, Zitong, Han, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250113/
https://www.ncbi.nlm.nih.gov/pubmed/30510448
http://dx.doi.org/10.2147/CMAR.S177473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250113/
https://www.ncbi.nlm.nih.gov/pubmed/30510448
http://dx.doi.org/10.2147/CMAR.S177473

Ejemplares similares